Fraser Moore1, Barbara Vickrey2, Kathy Fortin3, Liesly Lee4. 1. 1Department of Neurology,Jewish General Hospital,McGill University,Montreal. 2. 2Department of Neurology,University of California,Los Angeles,California,USA. 3. 3Department of Medical Affairs,Boisbriand,Quebec. 4. 4Division of Neurology,Sunnybrook Health Science Center,Toronto,Ontario,Canada.
Abstract
BACKGROUND: Multiple sclerosis (MS) has a profound impact on patients' health-related quality of life (HRQoL). It is unclear how HRQoL can be best assessed for different purposes. This study aimed to compare two HRQoL questionnaires of differing lengths for feasibility of administration, patient perceptions and psychometric properties. METHODS: This was an open-label, 24-month study in 334 patients with relapsing MS treated with subcutaneous interferon β-1a. At baseline and months 6, 12, 18 and 24, patients completed the Multiple Sclerosis International Quality of Life (MusiQoL) and Multiple Sclerosis Quality of Life-54 (MSQOL-54) questionnaires and compared them using an evaluation questionnaire. HRQoL scores over time and psychometric properties (correlations with clinical disease measures, relative validity and responsiveness to change) of the questionnaires were assessed. RESULTS: A minority of patients had missing items on either HRQoL measure. Completion time was significantly shorter for MusiQoL versus MSQOL-54 (p<0.0001). Patients felt that MusiQoL was easier to use than MSQOL-54 but preferred MSQOL-54 in terms of thoroughness. Mean HRQoL scores increased significantly from baseline to 24 months; correlations of both measures were stronger with an anxiety and depression measure than with disability or recent relapse occurrence. Relative validity and responsiveness to change were similar for both instruments. CONCLUSION: The shorter MusiQoL is suitable for evaluating HRQoL in patients with MS and may be more practical to administer than the more thorough MSQOL-54.
BACKGROUND:Multiple sclerosis (MS) has a profound impact on patients' health-related quality of life (HRQoL). It is unclear how HRQoL can be best assessed for different purposes. This study aimed to compare two HRQoL questionnaires of differing lengths for feasibility of administration, patient perceptions and psychometric properties. METHODS: This was an open-label, 24-month study in 334 patients with relapsing MS treated with subcutaneous interferon β-1a. At baseline and months 6, 12, 18 and 24, patients completed the Multiple Sclerosis International Quality of Life (MusiQoL) and Multiple Sclerosis Quality of Life-54 (MSQOL-54) questionnaires and compared them using an evaluation questionnaire. HRQoL scores over time and psychometric properties (correlations with clinical disease measures, relative validity and responsiveness to change) of the questionnaires were assessed. RESULTS: A minority of patients had missing items on either HRQoL measure. Completion time was significantly shorter for MusiQoL versus MSQOL-54 (p<0.0001). Patients felt that MusiQoL was easier to use than MSQOL-54 but preferred MSQOL-54 in terms of thoroughness. Mean HRQoL scores increased significantly from baseline to 24 months; correlations of both measures were stronger with an anxiety and depression measure than with disability or recent relapse occurrence. Relative validity and responsiveness to change were similar for both instruments. CONCLUSION: The shorter MusiQoL is suitable for evaluating HRQoL in patients with MS and may be more practical to administer than the more thorough MSQOL-54.
Authors: Kirsten M Fiest; Jamie Greenfield; Luanne M Metz; Scott B Patten; Nathalie Jetté; Ruth Ann Marrie Journal: Health Qual Life Outcomes Date: 2017-12-21 Impact factor: 3.186
Authors: Barbara Seebacher; Birgit Helmlinger; Daniela Pinter; Rainer Ehling; Harald Hegen; Stefan Ropele; Gernot Reishofer; Christian Enzinger; Christian Brenneis; Florian Deisenhammer Journal: BMJ Open Date: 2022-02-07 Impact factor: 2.692
Authors: Jansirani Natarajan; Mickael Antoine Joseph; Abdullah Al Asmi; Gerald Amandu Matua; Jaber Al Khabouri; Anitha Nesa Thanka; Laila Darwish Al Balushi; Suad Moosa Al Junaibi; Issa Sulaiman Al Ismaili Journal: Oman Med J Date: 2021-11-15
Authors: Rosalba Rosato; Silvia Testa; Antonio Bertolotto; Paolo Confalonieri; Francesco Patti; Alessandra Lugaresi; Maria Grazia Grasso; Anna Toscano; Andrea Giordano; Alessandra Solari Journal: PLoS One Date: 2016-04-14 Impact factor: 3.240